Jonathan Northrup

Jonathan Northrup Email and Phone Number

CEO, CoFounder, Board Member @ Stingray Therapeutics
Dallas, TX, US
Jonathan Northrup's Location
Dallas, Texas, United States, United States
About Jonathan Northrup

2018-Current: CEO & Cofounder Stingray Therapeutics, Immune Oncology - developing the inhibitor of the direct negative, cancer upregulated protein to block innate immunity2018-Current: Board Member & Co-founder - Iterion Therapeutics (Beta Cat Pharmaceuticals) - first safe & effective nuclear beta catenin inhibitor2010-June 2018 CEO & Founder2018-Current: Chair - Far Biotech, next level quantum design for in silico drug discovery across 50 billion possible compounds and scaffold hopping2019-Current: Advisor - Cell Source (CLCS) Immune tolerance for safer (no immune suppression) and more effective (higher cures with CAR-T) cancer treatment and organ transplantation2015-June 2020 Chair & Co-founder - Salarius Pharmaceuticals (SLRX-Nasdaq) Epigenetic modulation important for innate immune oncology and synthetic lethality in SWI/SNF mutations, orphan indication in teenage sarcomas2011-2015 CEO & Chair, Salarius2007-2010 COO, Jubilant InnovationA drug development/venture capital company in Bangalore, India2004-2006 Founder&CEO, Horizon Biotechnologiespharmaceutical R&D services from China,Korea and India. 2004-ELI Lilly; retired after 28 years2002-2004 Corporate Strategy and Business Development, SVP, Strategy and MarketingMarketing group that supports all bus dev added to responsibilities1999–2002 VP, Corporate Strategy, Strategic Asset Management1998 Internal Medicine Senior Director, Strategy,Business Development & New Product Planning 1995–1997 Corporate Business Development, Director - Lead negotiator in over forty alliances including alliances with Elan, Ligand, Protein Design Labs, Vertex, Roche, Seragen, Cubist, Dura, ILEX Oncology, Onyx, Scios, Roberts and Sibia. 1993–1994 Manager, Corporate Business Development; Built the Lilly cancer business through alliances, JVs, spin outs or build within. 1990–1992 Lilly Chicago South,District Sales Manager#1 in Nation for Axid,15 sales representative district.1989 Marketing Studies Manager-LoVan-Developed the marketing effort to launch Prozac for Obesity1987-88 Market Research Manager, Launched Prozac1986 Marketing Studies Manager-Prozac Axid Humatrope Keftab1985 New Product Planning - Infectious Diseases

Jonathan Northrup's Current Company Details
Stingray Therapeutics

Stingray Therapeutics

View
CEO, CoFounder, Board Member
Dallas, TX, US
Jonathan Northrup Work Experience Details
  • Stingray Therapeutics
    Ceo, Cofounder, Board Member
    Stingray Therapeutics
    Dallas, Tx, Us
  • Vasculonics
    Board Member And Advisor, Vasculonics
    Vasculonics Sep 2020 - Present
  • Stingray Therapeutics
    Ceo, Cofounder, Board Member
    Stingray Therapeutics Jun 2018 - Present
    Houston, Texas, Us
    Stingray is pioneering the next revolution in immune oncology modulators, with inhibitors of ENPP1, an important regulator of the innate immune system with novel applications for immune oncology and infectious diseases.
  • Iterion Therapeutics
    Board Member
    Iterion Therapeutics Jun 2018 - Present
    Houston, Texas, Us
  • Salarius Pharmaceuticals
    Board Member And Cofounder
    Salarius Pharmaceuticals Jan 2012 - Present
    Houston, Texas, Us
  • Beta Cat Pharmaceuticals
    Ceo, Board Member, Cofounder
    Beta Cat Pharmaceuticals Mar 2011 - Jun 2018
    Beta Cat has small molecules which inhibit beta catenin, an important cancer target that has been notoriously difficult to drug. This key protein at the bottom of the WNT embryonic stem cell pathway is taken over by many cancers to allow them to be resistant to many standards of care in oncology - including chemo-therapies, targeted therapies and even the newest immune oncology therapies.In addition, several orphan cancers appear to be highly dependent on beta catenin, such as desmoid tumors and perhaps germinal center B cell lymphomas. AML in combination with other standards of care is also a place where beta catenin activity is very important.Beta Cat has been building a team at the JLABS incubator in Houston and is advancing its lead compound into clinical studies in the near future.Beta Cat is funded by Sante Ventures who have lead the Series A round, and has a $16 MM award from the Cancer Prevention and Research Institute of Texas.
  • Jubilant Innovation
    Coo
    Jubilant Innovation Jan 2007 - Mar 2011
    Founding head of venturing group for Jubilant Life Sciences, a large Indian contract research company doing CMC, discovery collaborations and clinical research. Jubilant Innovation in licensed translational drug development molecules in a codevelopment motiff and did the translational activities within Jubilant.
  • Horizon Biotechnologies
    Ceo & Founder
    Horizon Biotechnologies 2004 - 2006
    Run a consultancy company that provides pharmaceutical services done in China, India and Korea to American Pharmaceutical and Biotechnology companies. Represent Chinese, Korean and Indian Companies technology for Business Development and licensing deals for USA and European markets
  • Eli Lilly
    Vp, Business Development & Strategy
    Eli Lilly 1996 - 2004
    Indianapolis, Indiana, Us

Jonathan Northrup Skills

Biotechnology Pharmaceutical Industry Oncology Lifesciences Clinical Development Drug Development Strategy Drug Discovery Licensing Technology Transfer Life Sciences Commercialization Cancer Clinical Trials Biopharmaceuticals R&d Venture Capital Business Development Infectious Diseases Corporate Development Start Ups Global Marketing Business Strategy Market Research Product Development Cro Entrepreneurship Pharmaceutics Medical Devices Vaccines Due Diligence Mergers And Acquisitions Competitive Intelligence Strategic Partnerships Strategic Alliances Clinical Research Technology Evaluation Pharmaceutical Sales Fda Immunology Business Alliances Venture Financing Market Analysis Angel Investing Market Access Global Business Development Building Companies Pharmaceuticals Strategy Development Alliances

Jonathan Northrup Education Details

  • The Wharton School
    The Wharton School
    Marketing
  • Northwestern University
    Northwestern University
    Economics
  • Northwestern University
    Northwestern University
    Economics
  • Northwestern University
    Northwestern University
    Economics

Frequently Asked Questions about Jonathan Northrup

What company does Jonathan Northrup work for?

Jonathan Northrup works for Stingray Therapeutics

What is Jonathan Northrup's role at the current company?

Jonathan Northrup's current role is CEO, CoFounder, Board Member.

What is Jonathan Northrup's email address?

Jonathan Northrup's email address is jo****@****ntx.com

What is Jonathan Northrup's direct phone number?

Jonathan Northrup's direct phone number is +131751*****

What schools did Jonathan Northrup attend?

Jonathan Northrup attended The Wharton School, Northwestern University, Northwestern University, Northwestern University.

What are some of Jonathan Northrup's interests?

Jonathan Northrup has interest in Exercise, Home Improvement, Reading, Gourmet Cooking, Sports, Golf, Home Decoration, Health, Diy, Cooking.

What skills is Jonathan Northrup known for?

Jonathan Northrup has skills like Biotechnology, Pharmaceutical Industry, Oncology, Lifesciences, Clinical Development, Drug Development, Strategy, Drug Discovery, Licensing, Technology Transfer, Life Sciences, Commercialization.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.